Analyst Reco. Shockwave Medical, Inc.

Equities

SWAV

US82489T1043

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
330 ^USD	+0.31%		+0.30%	+73.17%

Apr. 11	Health Care Slips on Risk Bias -- Health Care Roundup	DJ
Apr. 09	CL King Downgrades ShockWave Medical to Neutral From Buy, Cuts Price Target to $335 From $368	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CL King Downgrades ShockWave Medical to Neutral From Buy, Cuts Price Target to $335 From $368	Apr. 09	MT
Leerink Partners Downgrades ShockWave Medical to Market Perform From Outperform, Cuts Price Target to $335 From $361	Apr. 08	MT
Deutsche Bank Downgrades ShockWave Medical to Hold From Buy, Raises Price Target to $335 From $270	Apr. 08	MT
Morgan Stanley Downgrades ShockWave Medical to Equal Weight From Overweight, Raises Price Target to $335 From $285	Apr. 08	MT
Wolfe Research Downgrades ShockWave Medical to Peer Perform From Outperform	Apr. 05	MT
Needham Downgrades ShockWave Medical to Hold From Buy	Apr. 05	MT
Piper Sandler Raises Price Target on ShockWave Medical to $360 From $290, Keeps Overweight Rating	Apr. 02	MT
CL King Initiates ShockWave Medical With Buy Rating, Price Target is $368	Mar. 27	MT
UBS Raises Price Target on ShockWave Medical to $250 From $228, Maintains Neutral Rating	Feb. 20	MT
Piper Sandler Raises ShockWave Medical's Price Target to $290 From $275, Keeps Overweight Rating	Feb. 16	MT
Needham Adjusts Price Target on ShockWave Medical to $286 From $260, Keeps Buy Rating	Feb. 16	MT
Morgan Stanley Raises Price Target on ShockWave Medical to $285 From $223, Keeps Overweight Rating	Feb. 16	MT
Morgan Stanley Cuts ShockWave Medical's Price Target to $223 From $284, Maintains Overweight Rating	Dec. 04	MT
Deutsche Bank Cuts ShockWave Medical Price Target to $270 From $310, Maintains Buy Rating	Nov. 07	MT
Piper Sandler Adjusts ShockWave Medical Price Target to $275 From $315, Maintains Overweight Rating	Nov. 07	MT
Needham Cuts Price Target on ShockWave Medical to $260 From $265, Maintains Buy Rating	Nov. 07	MT
Morgan Stanley Cuts Price Target on ShockWave Medical to $284 From $313, Notes 'Peripheral Softness,' Keeps Overweight Rating	Nov. 07	MT
UBS Adjusts ShockWave Medical Price Target to $226 From $218, Maintains Neutral Rating	23-10-24	MT
Needham Lowers ShockWave Medical's PT to $265 From $330 Due to Peer Multiple Contraction, Keeps Buy Rating	23-10-24	MT
BofA Slashes Price Target on ShockWave Medical to $250 From $316, Keeps Buy Rating	23-10-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Shockwave Medical, Inc.

Equities

SWAV

US82489T1043

Analyst Reco.

Filters